Position in LLY
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$147,529
+$28,879 QoQ
Shares Held
123
-4.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#4,459
of 4,604 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sankala Group LLC holds $1,601,128 across 8 Drug Manufacturers - General names. LLY ranks #4 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
12,306 | $589,949 | |
| 2 | ABBV |
AbbVie Inc.
|
2,071 | $521,146 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
2,406 | $303,974 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
123 | $147,529 | |
| 5 | MRK |
Merck & Co., Inc.
|
231 | $29,683 | |
| 6 | JNJ |
Johnson & Johnson
|
30 | $7,619 | |
| 7 | PFE |
Pfizer Inc
|
36 | $866 | |
| 8 | AMGN |
Amgen Inc
|
1 | $362 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $147,529 | 123 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $118,650 | 129 | Shares | Sole | 2026-03-31 | |
| 2025-12-31 | $138,633 | 129 | Shares | Sole | 2026-03-02 | |
| No filing history on record for this holder in this stock. | ||||||